<?xml version="1.0"?>
<Articles JournalTitle="Immunology and Genetics Journal">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Immunology and Genetics Journal</JournalTitle>
      <Issn>2645-4831</Issn>
      <Volume>5</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2022</Year>
        <Month>09</Month>
        <Day>22</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">COVID-19-Related Hypercoagulability as a Long-term Complication in SARS-CoV-2: Lessons from SARS and MERS</title>
    <FirstPage>99</FirstPage>
    <LastPage>102</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Elahe</FirstName>
        <LastName>Mohammadi Jorjafki</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Karimizadeh</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Shahi</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Hanye</FirstName>
        <LastName>Sohrabi</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>01</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a various clinical and laboratory findings in affected patients. Similar to the previous outbreak, patients with SARS-CoV-2 showed elevated levels of D-dimer, thrombocytopenia, and prolonged prothrombin time and the activated partial thromboplastin time. Meanwhile two lethal coagulation disorders of disseminated intravascular coagulation and pulmonary embolism have already been reported in patients with SARS-CoV-2. Although further cohort studies are needed to document long-term complications, considering the similar pathogenicity of SARS-CoV and SARS-CoV-2, the same chronic cardiovascular impairments could be expected.</abstract>
    <web_url>https://igj.tums.ac.ir/index.php/igj/article/view/115</web_url>
    <pdf_url>https://igj.tums.ac.ir/index.php/igj/article/download/115/104</pdf_url>
  </Article>
</Articles>
